← Home
No Priors · June 10, 2026 · 56m

Biohub: The Future of Biology is Open-Source with Co-Founders Mark Zuckerberg, Priscilla Chan, and Head of Science Alex Rives

Alex Rives, Elad Gil, Mark Zuckerberg, Priscilla Chan, Sarah Guo
Show Notes

Biohub co-founders Mark Zuckerberg and Priscilla Chan, alongside Head of Science Alex Rives, discuss their $500 million virtual biology initiative integrating frontier AI with wet-lab work to build predictive models of cells and proteins. They announce ESMFold2, an open-source engine for digital protein and antibody design, and explain why Biohub operates as a nonprofit rather than a venture-backed startup. The conversation explores how hierarchical simulations could enable mechanistic, individualized medicine and accelerate the timeline for curing disease.

This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.

Curious

•
Hierarchical Biological Simulations Enable Mechanistic, Individualized Medicine24:23
Virtual cell and tissue simulations will allow doctors to understand disease mechanisms at the individual level, moving from population-level treatment protocols to personalized interventions based on a patient's specific cellular dynamics.
ClaudeChatGPTGemini
•
Mechanistic Interpretiability in Biology: Understanding HOW, Not Just Predicting WHAT14:22
Rather than treating biology as a black box (we observe outcomes but don't know why), Biohub focuses on mechanistic interpretiability—building models that reveal the causal steps that lead from genes to phenotype to disease.
ClaudeChatGPTGemini

Novel

•
ESMFold2: Open-Source Protein Design Engine28:04
Biohub released ESMFold2, an open-source computational tool for predicting protein structures and designing novel antibodies and therapeutics, making frontier protein design accessible to researchers globally.
ClaudeChatGPTGemini

Highlights

•
AI + Biology Convergence Makes Disease Eradication Tractable01:26
Frontier AI combined with vast biological datasets enables predictive modeling of disease mechanisms at molecular and systemic levels, making the goal of curing all disease by century's end potentially too conservative.
ClaudeChatGPTGemini

Editorial

•
Nonprofit Structure Aligns Incentives With Research Impact, Not Financial Returns16:58
Biohub structured itself as a nonprofit because curing disease is a public good that doesn't maximize venture returns, allowing long-term focus on problems that may take decades to solve.
ClaudeChatGPTGemini

Misc

✧Biohub's original mission (curing all disease by century's end) may have been 'too conservative' given AI+biology convergence
✧ESMFold2 is being released open-source, not as proprietary technology
✧Nonprofit structure chosen explicitly to prioritize research impact over financial returns
✧Focus on 'mechanistic interpretiability' in biology — understanding HOW disease happens, not just patterns
✧Virtual cell simulations could enable treatment at the individual, mechanistic level rather than population-level protocols
Was this useful?